Pharma Stability: Insights, Guidelines, and Expertise
SOP for Addressing Stability Testing Requirements for Global Harmonization under ICH Guidelines Procedure for Stability Testing for Global Harmonization 1) Purpose The purpose of this SOP is to define a procedure for conducting stability testing to meet global harmonization requirements as outlined by the International Council for Harmonisation (ICH) guidelines. This ensures that drug products…
SOP for Implementing Stability Testing for Orally Inhaled and Nasal Drug Products (OINDP) under FDA Guidelines Procedure for Stability Testing of Orally Inhaled and Nasal Drug Products 1) Purpose The purpose of this SOP is to define a procedure for conducting stability testing for orally inhaled and nasal drug products (OINDP) in accordance with US…
SOP for Conducting Stability Studies for Controlled Drugs under Regulatory Guidelines Procedure for Stability Testing of Controlled Drugs 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability studies for controlled drugs in compliance with relevant regulatory guidelines. This ensures that controlled substances maintain their quality, safety, and efficacy throughout…
Read More “SOP for Conducting Stability Studies for Controlled Drugs under Regulatory Guidelines” »
SOP for Addressing Stability Testing for Products under Emergency Use Authorization (EUA) Procedure for Stability Testing of Products under Emergency Use Authorization 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability testing for products under Emergency Use Authorization (EUA) in compliance with regulatory guidelines. This ensures that products maintain…
SOP for Implementing Stability Testing for High-Risk Drug Products under Regulatory Guidelines Procedure for Stability Testing of High-Risk Drug Products 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability testing of high-risk drug products in compliance with relevant regulatory guidelines. This ensures that these products maintain their safety, efficacy,…
SOP for Conducting Stability Studies for Drugs with Narrow Therapeutic Index under US FDA Guidelines Procedure for Stability Testing of Drugs with Narrow Therapeutic Index 1) Purpose The purpose of this SOP is to define the procedure for conducting stability studies for drugs with a narrow therapeutic index in compliance with US FDA guidelines. This…
SOP for Implementing Stability Testing for Non-Oral Dosage Forms in Compliance with Regulatory Guidelines Procedure for Stability Testing of Non-Oral Dosage Forms 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability testing of non-oral dosage forms (e.g., injectables, topical, inhalation) in compliance with relevant regulatory guidelines. This ensures that…
SOP for Conducting Stability Testing for Biologics Under Biosimilar Regulatory Guidelines Procedure for Stability Testing of Biologics in Compliance with Biosimilar Regulations 1) Purpose The purpose of this SOP is to define the procedures for conducting stability testing of biologics under biosimilar regulatory guidelines. This ensures that biosimilar products meet the required standards of quality,…
SOP for Addressing Stability Testing for Breakthrough Therapy Drugs under FDA Guidelines Procedure for Stability Testing of Breakthrough Therapy Drugs 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability testing of breakthrough therapy drugs in compliance with US FDA guidelines. This ensures that these drugs maintain their intended quality,…
SOP for Implementing ICH Q1A(R2) for Stability Testing of APIs and Drug Products Procedure for Stability Testing According to ICH Q1A(R2) Guidelines 1) Purpose The purpose of this SOP is to define the procedures for implementing the ICH Q1A(R2) guidelines for the stability testing of active pharmaceutical ingredients (APIs) and drug products. This ensures that…
Read More “SOP for Implementing ICH Q1A(R2) for Stability Testing of APIs and Drug Products” »